Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 13.9% |
| 4 | Consumer Discretionary | 13.25% |
| 5 | Industrials | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTLF
1501
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.03M | ﹤0.01% |
20,761
-2,381
| -10% | -$112K |
|
1502
Federal Signal
FSS
$7.31B
| $1.03M | ﹤0.01% |
31,946
+1,211
| +4% | +$39.5K |
|
|
VLRS
1503
Controladora Vuela Compania de Aviacion
VLRS
$798M
| $1.03M | ﹤0.01% |
+98,429
| New | +$1.05M |
|
1504
Compañía de Minas Buenaventura
BVN
$8.94B
| $1.02M | ﹤0.01% |
67,858
+8,208
| +14% | +$122K |
|
|
DCOM
1505
DELISTED
Dime Community Bancshares
DCOM
| $1.02M | ﹤0.01% |
49,071
-473
| -1% | -$9.7K |
|
|
PFNX
1506
DELISTED
Pfenex Inc.
PFNX
| $1.02M | ﹤0.01% |
92,700
+67,348
| +266% | +$669K |
|
1507
Thor Industries
THO
$4.13B
| $1.01M | ﹤0.01% |
13,647
-16,291
| -54% | -$1.05M |
|
1508
TriNet
TNET
$3.19B
| $1.01M | ﹤0.01% |
17,887
-2,706
| -13% | -$151K |
|
1509
Shenandoah Telecom
SHEN
$681M
| $1.01M | ﹤0.01% |
24,317
-107,723
| -82% | -$3.81M |
|
1510
Scorpio Tankers
STNG
$3.92B
| $1.01M | ﹤0.01% |
25,732
+13,048
| +103% | +$446K |
|
|
DCH
1511
Dauch Corp
DCH
$1.53B
| $1.01M | ﹤0.01% |
93,496
+54,706
| +141% | +$521K |
|
1512
American Superconductor
AMSC
$1.4B
| $1M | ﹤0.01% |
127,692
-253,349
| -66% | -$2.04M |
|
1513
NovaGold Resources
NG
$4.1B
| $999K | ﹤0.01% |
111,468
+16,921
| +18% | +$117K |
|
1514
Freeport-McMoran
FCX
$112B
| $998K | ﹤0.01% |
76,291
+25,173
| +49% | +$276K |
|
1515
Zscaler
ZS
$28.5B
| $997K | ﹤0.01% |
21,475
-49,580
| -70% | -$2.3M |
|
|
NETI
1516
DELISTED
Eneti Inc.
NETI
| $997K | ﹤0.01% |
15,650
-14,769
| -49% | -$898K |
|
1517
Watts Water Technologies
WTS
$12.4B
| $994K | ﹤0.01% |
9,959
+1,876
| +23% | +$178K |
|
1518
Costamare
CMRE
$1.88B
| $989K | ﹤0.01% |
103,792
+32,660
| +46% | +$261K |
|
1519
TechTarget
TTGT
$276M
| $989K | ﹤0.01% |
37,890
-53,494
| -59% | -$1.36M |
|
1520
Sensata Technologies
ST
$6.11B
| $987K | ﹤0.01% |
18,316
-30,051
| -62% | -$1.54M |
|
1521
Voyager Therapeutics
VYGR
$212M
| $983K | ﹤0.01% |
70,456
-7,449
| -10% | -$108K |
|
|
BPMC
1522
DELISTED
Blueprint Medicines
BPMC
| $975K | ﹤0.01% |
12,167
+3,112
| +34% | +$233K |
|
1523
Miller Industries
MLR
$644M
| $970K | ﹤0.01% |
+26,114
| New | +$918K |
|
|
LTC
1524
LTC Properties
LTC
$2.18B
| $965K | ﹤0.01% |
21,559
-1,010
| -4% | -$48.5K |
|
1525
Itron
ITRI
$4.32B
| $956K | ﹤0.01% |
11,387
+3,733
| +49% | +$294K |
|
Similar funds
Cliff Asness's Q4 2019 Portfolio in Review
As of Q4 2019, Cliff Asness held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cliff Asness opened a new position in DaVita worth $31.1M.
- Cliff Asness's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- Cliff Asness added most to Humana in Q4 2019, an estimated $267M increase.
- Cliff Asness's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- Cliff Asness fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- Cliff Asness's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- Cliff Asness opened 146 new positions and closed 142 in Q4 2019.
- Cliff Asness's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.